Clinical Trial

The Use of Butyrate Therapy in Pediatric Ulcerative Colitis

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.
Trial Details
NCT Number NCT05218850
Lead Sponsor Children's Hospital Los Angeles
Conditions Ulcerative Colitis
Enrollment 10 participants
Start Date 2022-06-29
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-04